<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-JEU4H14X</identifier><date>2022</date><creator>Avsec, Damjan</creator><creator>Mlinarič-Raščan, Irena</creator><creator>Podgornik, Helena</creator><relation>documents/doc/J/URN_NBN_SI_doc-JEU4H14X_001.pdf</relation><relation>documents/doc/J/URN_NBN_SI_doc-JEU4H14X_001.txt</relation><format format_type="issue">1</format><format format_type="volume">73</format><format format_type="type">article</format><format format_type="extent">str. 31-39</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">103039747</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-JEU4H14X</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">Apoptoza</subject><subject language_type_id="slv">Bcl-2</subject><subject language_type_id="slv">Kronična limfocitna levkemija</subject><subject language_type_id="slv">navitoklaks</subject><subject language_type_id="slv">obatoklaks</subject><subject language_type_id="slv">S55746</subject><subject language_type_id="slv">venetoklaks</subject><title>Antagonists of antiapoptotic proteins in the targeted therapy of chronic lymphocytic leukemia</title><title>Tarčno zdravljenje kronične limfocitne levkemije z antagonisti antiapoptotičnih proteinov</title></Record>